Supernus Pharmaceuticals SUPN
Last Price
52 Week Range
$29.16 - $57.65
Next Earnings Date
Feb 24 2026 (Estimate)
Next Earnings Date
Feb 24 2026 (Est.)
Last Price
SUPN Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Supernus Pharmaceuticals, Inc. | 10-Q | November 6, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | November 4, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | October 21, 2025 | |
Supernus Pharmaceuticals, Inc. | 10-Q | August 5, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | August 5, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | August 4, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | July 31, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | June 17, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | June 16, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | May 28, 2025 | |
Supernus Pharmaceuticals, Inc. | 10-Q | May 6, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | May 6, 2025 | |
Supernus Pharmaceuticals, Inc. | DEF 14A | April 30, 2025 | |
Supernus Pharmaceuticals, Inc. | DEFA14A | April 30, 2025 | |
Supernus Pharmaceuticals, Inc. | ARS | April 30, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | April 23, 2025 | |
Supernus Pharmaceuticals, Inc. | 10-K | February 25, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | February 25, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | February 24, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | February 18, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | February 11, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | February 4, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | January 27, 2025 | |
Supernus Pharmaceuticals, Inc. | 8-K | December 20, 2024 | |
Supernus Pharmaceuticals, Inc. | 10-Q | November 4, 2024 | |
Supernus Pharmaceuticals, Inc. | 8-K | November 4, 2024 | |
Supernus Pharmaceuticals, Inc. | 8-K | October 30, 2024 | |
Supernus Pharmaceuticals, Inc. | 8-K | October 21, 2024 | |
Supernus Pharmaceuticals, Inc. | 8-K | October 17, 2024 | |
Supernus Pharmaceuticals, Inc. | 8-K | October 10, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.